CD4 and acute lymphoblastic leukemia: After in vitro functional validation of our CAR-T cell products, we got interested in deciphering the contribution of individual CD4 and CD8 CAR-T cells in triggering detrimental toxicities, particularly CRS, in B-ALL context.